Analysis of MMP-9 and TIMP-2 gene promoter polymorphisms in individuals with hypodontia by Peres, Regina C.R. & Line, Sérgio R.P.
Braz Dent J 16(3) 2005
MMP-9 and TIMP-2 promoter polymorphisms and hypodontia 231
Analysis of MMP-9 and TIMP-2 Gene Promoter
Polymorphisms in Individuals with Hypodontia
Regina C.R. PERES
Sérgio R.P. LINE
Department of Morphology, Faculty of Dentistry of Piracicaba,
State University of Campinas (UNICAMP), Piracicaba, SP, Brazil
Hypodontia, the congenital absence of one or a few teeth, is one of the most common developmental alterations of human dentition. It
may cause masticatory and speech dysfunctions and create esthetic problems with orthodontic and prosthetic implications. MMP-9
is an important member of the matrix metalloproteinase (MMP) family that participates in remodeling of extracellular matrix during
tooth development. A C-to-T base exchange at position -1562 creates two different alleles, and the CT and TT genotypes promote high
activity of the MMP-9 gene promoter. Tissue inhibitor of metalloproteinase-2 (TIMP-2) regulates the activity of MMPs in the
extracellular matrix and is co-expressed with gelatinases A (MMP-2) and B (MMP-9) during mouse tooth morphogenesis. A
polymorphism in the TIMP-2 gene promoter at position -418 has been found in a Sp-1 binding site. In this study, the association
between these DNA polymorphisms and hypodontia has been investigated. The significance of differences in frequencies of
polymorphisms in control and test groups was assessed by Chi-square test (p<0.05). Data suggested that MMP-9 gene promoter
polymorphism was not associated with hypodontia. The high frequency of GG genotype in the TIMP-2 gene promoter showed that
this site was unsuitable for studies of DNA polymorphism-disease associations in the studied population.
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INTRODUCTION
Hypodontia, the congenital absence of one or a
few teeth, is one of the most common developmental
alterations of human dentition. Although it is not a
serious public health problem, hypodontia may cause
masticatory and speech dysfunctions and create esthetic
problems with orthodontic and prosthetic implications.
Over the past few years, the importance of several
genes in tooth development has been shown by the lack
of teeth in mutant knockout mice models (1). Autosomal
dominant forms of tooth agenesis are due to mutations
in human MSX1, PAX9 and AXIN2 genes (2,3).
However, the origin of hypodontia, the most common
form of tooth agenesis in humans, remains uncertain.
Although the exact molecular mechanisms involved in
tissue interactions that regulate tooth development are
unknown, there is evidence that extracelullar matrix
(ECM) molecules may play a major role (4).
In addition to provide a scaffold for cell adhesion
and migration, the ECM also has an important role on the
modulation of cell behavior (5). ECM molecules can
recruit and store signaling molecules. Moreover, ECM
components can act as signaling molecules themselves.
The turnover of ECM is mainly regulated by a class of
proteolytic enzymes known as matrix metalloproteinases
(MMPs). MMPs constitute an important family of zinc-
dependent endopeptidases, which are able to degrade
most, if not all, components of extracellular matrix (6).
The activity of metalloproteinases on  ECM is regulated
by specific MMPs inhibitors, known as tissue
metalloproteinases inhibitors (TIMPs). The TIMP family
consists of four members: TIMP-1, -2, -3 and -4. These
molecules inhibit the proteolytic activity of activated
MMPs by forming a 1:1 stoichiometric inhibitory
complex with the enzyme. TIMP-2 is coexpressesed
with gelatinases A (MMP-2) and B (MMP-9) during
mouse tooth morphogenesis. Disturbances in MMP-
TIMP interactions have been implicated in the etiology
of some diseases, such as arthritis, pulmonary
emphysema, atherosclerosis and periodontitis, in which
the loss of ECM is a major feature (7).
MMP-9 and TIMP-2 participate in the remodeling
of tooth-specific matrices that accompanies the
developmental events as these molecules are expressed
during early tooth development (8,9). However, there
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are no studies correlating disturbances in MMP9 or
TIMP2 expression in tooth development. MMP-9 gene
presents a functional C-to-T single nucleotide
polymorphism (SNP) at position -1562, which affects
transcription. The CC genotype has been shown to
decrease transcriptional activity (10). This MMP-9
polymorphism has been associated with high risk for
vascular diseases, such as coronary atherosclerosis
(10). A polymorphism in the TIMP-2 gene promoter at
position -418 has been described and corresponds to a
G to C substitution in a consensus sequence for the Sp1
binding site (11). Polymorphisms in the promoter region
of TIMP-2 gene have been associated with chronic
obstructive pulmonary disease (11). Because such
polymorphisms alter the expression of MMP-9 and
TIMP-2 genes, the analysis of their distribution in
populations bearing tooth agenesis may provide a direct
evidence of the importance of these genes on the
development of dentition in humans. In this study, the
association between these DNA polymorphisms and
hypodontia has been investigated.
MATERIAL AND METHODS
Fifty-two unrelated Caucasian individuals with
hypodontia (Fig. 1) and 48 healthy Caucasian control
individuals (without hypodontia) were interviewed and
documented. Congenital absence of teeth was confirmed
radiographically. No other dental anomalies were
observed. For sampling of epithelial buccal cells, the
volunteers undertook 5 mL of 3% glucose mouthwash
and the oral mucosa was scraped with a sterile wooden
spatula. The tip of the spatula was then shacked into the
retained mouthwash solution. Oral epithelial cells were
pelleted by centrifugation at 2000 rpm for 10 min. The
supernatant was discarded and the cell pellet was
resuspended in 500 μL extraction buffer [10 mM Tris-
HCl (pH 7.8), 5 mM EDTA, 0.5% SDS]. The samples
were then frozen at -20oC until use for DNA extraction.
After defrost, samples were incubated overnight with
100 ng/mL proteinase K (Sigma Chemical Co., St.
Louis, MO, USA) at 37°C with agitation. DNA was then
purified by sequential phenol/chloroform extraction and
salt/ethanol precipitation. DNA was dissolved in 70 μL
TE buffer [10 mM Tris (pH 7.8), 1 mM EDTA]. The
concentration was estimated by measurements of OD260.
Thereafter, the sequence from -1809 to -1374 in
MMP-9 gene promoter was amplified by polymerase
chain reaction (PCR) with primers 5‘-
GCCTGGCACATAGTAGGCCC-3‘ (forward) and 5‘-
CTTCCTAGCCAGCCGGCATC -3‘ (reverse). PCR
was done  in a total volume of 50 μL, containing 500 ng
genomic DNA, 10 mM Tris-HCl (pH 8.3), 50 mM KCl,
1.5 mM MgCl2, 1 μM of each primer, 200 μM each
dATP, dCTP, dGTP and dTTP, and 2.5 units Taq DNA
polymerase (Amersham Pharmacia Biotech AB, Uppsala,
Sweden). The solution was incubated for 3 min at 95°C,
followed by 35 cycles of 1 min at 95°C, 45 s at 65°C and
45 s at 72°C, with a 7-min final extension at 72°C.
A fragment of 176 bp of the TIMP-2 gene
promoter was PCR amplified with primers 5’-
GGATCCTGTCAGTTTCTCAA-3’ (forward); 5’-
TTTCCCCTTAGCTCGACTCT-3’ (reverse). PCR was
carried out in a total volume of 50 μL, containing 500 ng
of genomic DNA, 10 mM Tris-HCl (pH 8.3), 50 mM
KCl, 1.5 mM MgCl2, 1 μM of each primer, 200 μM of
each dATP, dCTP, dGTP and dTTP, and 4 units of Taq
DNA polymerase (Amersham Pharmacia Biotech AB).
The solution was incubated for 3 min at 95°C, followed
by 35 cycles of 1min at 95°C, 1 min at 55°C, and 1 min
at 72°C, with a final extension of 72°C for 7 min.
A 4-μL aliquot of MMP-9 PCR products was
mixed with a 8 μL solution containing 1 μL 10x NE
Buffer (50 mM NaCl, 10 mM Tris-HCl, 10 mM MgCl2,
1 mM dithiothreitol, pH 7.9), 0.3 μL PaeI (20,000 units/
mL) (New England Biolabs, Inc., Beverly, MA, USA)
and 6.7 μL sterile deionized H2O. The solution was
incubated at 37°C for 16 h. For analysis of TIMP-2
polymorphism, a 3-μL aliquot of TIMP-2 PCR products
was mixed with a 17 μL solution containing 2 μL 10x NE
Buffer (50 mM NaCl, 10 mM Tris-HCl, 10 mM MgCl2,
1 mM dithiothreitol, pH 7.9), 0.5 μL HgaI (2,000 U/mL)
(New England Biolabs, Inc.) and 14.5 μL sterile deionized
H2O. The solution was incubated at 37°C for 16 h. The
digest was mixed 5 μL of loading buffer and
electrophoresed on a 10% vertical polyacrylamide gel.
The DNA bands were evidenced by the rapid silver
staining method (12).
The significance of  differences in frequencies of
polymorphisms in both groups was assessed by Chi-
squared test (x2). Clump software was used to assess
differences between control and test groups. This
program is designed for use in genetic case-control
studies where multiple alleles are being considered and
the observed frequencies of some alleles are rare (13).
Statistically significant differences were set at p<0.05.
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Figure 1. Genotypes and profile of permanent dentition in affected individuals. The first column indicates the genotypes of C-1562T
polymorphic site. The numbers in the vertical rows represent the tooth group (1 = central incisors; 2 = lateral incisors; 3 = canines; 4
and 5 = 1st and 2nd premolars; 6, 7 and 8 = 1st, 2nd and 3rd molars). L= left quadrant, R= right quadrant. * = missing teeth.
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RESULTS
There was no association between the allele
frequencies for polymorphism in the MMP-9 gene
promoter and hypodontia (p =0.4342). The same was
found for the different genotypes (p =0.3236). The C
allele was observed at 92.7% and 88.5% frequencies,
and the T allele was found at 7.3% and 11.5% frequencies,
in the control and test groups, respectively (Table 1).
The TT genotype, which is believed to increase MMP-
9 transcription, was not observed in either control or
test groups. The CT genotype was observed at
frequencies of 14.6% and 23% in the control and test
groups, respectively, while the CC genotype was
observed at frequencies of 85.4% and 77% in control
and test groups, respectively (Table 1). The TIMP-2
polymorphism analysis showed that the C allele was not
present in the studied population.
DISCUSSION
Gene polymorphisms are a mechanism by which
individuals may exhibit variations within the range of
what is considered biologically normal. Single nucleotide
polymorphisms (SNPs) occur at a high frequency in
human genome and can affect gene function.
Polymorphisms in the cis-acting sequences of MMPs
have been associated with several diseases (14). There
is a positive association between the presence of the
MMP-9 C-1562T SNP and inflammatory diseases (10).
The C-to-T exchange alters the binding of nuclear
proteins to this region, leading to increased transcriptional
activity in macrophages (10). The expression of MMP-
9 is primarily controlled at the transcriptional level,
where the promoter of the gene responds to stimuli of
various cytokines and growth factors (15). During
mouse tooth development, MMP-9 is expressed by
mesenchymal cells at bud and cap stages. The expression
of this gene is particularly intense around the tip of the
growing epithelial organ. Its expression decreases
progressively and no transcripts can be detected in
dental mesenchyme after the cap stage (8). These
results indicate a direct association between the
expression of MMP-9 with epithelial morphogenesis. It
is worth mentioning that MMP-2 or gelatinase A is
widely expressed by mesenchymal cells during tooth
development resulting in an overlapping expression of
these enzymes at the tip of the growing epithelial bud
(8). Therefore, it is possible that the lack of association
between the C-1562T polymorphism in the MMP-9
promoter found in the present study occurred due to a
functional redundancy between these two MMPs. Gene
redundancy is a mechanism devised to assure correct
performance of key developmental processes, and it
seems to be a frequent phenomena during the early
phases of tooth organogenesis (2).
TIMP-2 is widely expressed in dental
mesenchyme during early tooth development. Changes
in the expression of this molecule could have an influence
on dental development. The G-418C polymorphism of
the TIMP-2 promoter is located in a Sp1 consensus
sequence (16). This polymorphism is located within a
519-bp segment upstream the major transcription
initiation site, which was shown
to contain active promoter
elements (17). It was suggested
that the G-418C-nucleotide
substitution in the consensus
sequence for Sp1 results in
down-regulation of the
transcription activity of TIMP-
2 gene. The high frequency of
GG genotype in the TIMP-2
gene promoter makes this site
not suitable for studies of DNA
p o l y m o r p h i s m - d i s e a s e
associations in the studied
population (17). However, this
polymorphism was associated
Table 1. Distribution of the MMP-9 allele and genotypes in the control and test group.
SNP* Control Group Test Group p value
(without hypodontia) (without hypodontia)
n % n %
C-1562T allele
C 89 92.7 92 88.5 0.4342
T 7 7.3 12 11.5 (chi-squared)
Genotype
CC 41 85.4 40 77 0.3236
TT 0 0 0 0 (Clump)
CT 7 14.6 12 23
*SNP = single-nucleotide polymorphism.
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with the development of chronic obstructive pulmonary
disease in a Japanese population (11). Almost thirty
percent of the individuals (29.68%) were heterozygous,
suggesting that this variant could be common in Oriental
subjects. Our results suggest that the frequency of the
C allele appears to be very low, or even absent, among
Caucasian subjects from the Southeastern region of
Brazil.
In addition to elucidate the role of genes in the
etiology of alterations of human dentition, the study of
mutations/polymorphisms in genes related with tooth
development could also help to answer relevant questions
of modern biology. One of these questions is how
genetic variations interfere with development and are
translated into changes in morphology that occur within
and among species. Changes in the number of teeth tend
to occur in the reverse order that teeth are formed during
development, which also characterizes the general pattern
of tooth loss observed during the evolution of placental
mammals (18). Like hypodontia, most evolutionary
changes in tooth number resulted from loss of one or
two elements, in most cases the last member of a tooth
group. Polymorphic genetic loci have been directly
associated with morphological variations in non-
vertebrates. As far as it could be ascertained, there is no
example of genetic polymorphism that causes
morphological variation in vertebrates (19). Studies of
DNA polymorphism-hypodontia associations seem to
provide an especially suitable model to understand the
association of gene polymorphisms and changes in
morphology. Teeth are serially homologous structures
and the effects of gene variations on their development
can be easily quantified (1,2). Individuals with distinct
polymorphic alleles may exhibit subtle and specific
phenotypic variations in dental patterning. In this sense,
studies that investigate possible associations between
gene polymorphisms and hypodontia may help to
elucidate the genetic mechanisms responsible for the
variation in the frequency of tooth agenesis that occur
in distinct human populations and ethnic groups (20).
Our data indicate that the C-1562T polymorphism
in the MMP-9 promoter is not associated with hypodontia.
This lack of association could be a consequence of the
sample size. However, the very high p-values found in
our statistical analysis are indicative that there is indeed
a lack of correlation. It is also possible that changes in
the transcriptional activity in the MMP-9 promoter
caused by the polymorphism are compensated by other
factors acting in the cascade of events that regulate
tooth development. Additionally, other polymorphisms
present in the coding sequence of MMP-9 and TIMP-
2 genes may have an effect on the development of tooth
germ.
RESUMO
Hipodontia, a ausência congênita de um ou poucos dentes, é uma
das alterações de desenvolvimento mais comuns da dentição
humana. Este problema pode causar disfunções na fala e mastigação
assim como criar problemas estéticos com implicações
ortodônticas e protéticas. A enzima MMP-9 é um membro
importante da família das metaloproteinases da matriz, que
participa da remodelação da matriz extracelular durante o
desenvolvimento do dente. Um polimorfismo genético que consiste
em uma troca C-T na posição –1562 cria dois alelos na região
promotora deste gene. Os genótipos CT e TT estão relacionados
com uma maior atividade deste gene. A proteína inibidora tecidual
de metaloproteinase-2 (TIMP-2) regula a atividade das MMPs
na matriz extracelular sendo co-expressa com as gelatinases A
(MMP-2) e B (MMP-9) durante a morfogênese dental. Um
polimorfismo na posição –418 no promotor do gene TIMP-2 foi
descrito em um sítio de ligação para o fator de transcrição Sp-1. O
objetivo do presente trabalho foi investigar a associação destes
polimorfismos genéticos com a hipodontia. A significância das
diferenças nas freqüências de polimorfismos observadas entre os
grupos teste e controle foi analisada pelo teste de Qui-quadrado
(p<0.05). Os resultados sugeriram que o polimorfismo na região
promotora do gene MMP-9 não está associado com a hipodontia.
A alta freqüência do genótipo GG no promotor do gene TIMP-2
demonstrou que este sítio não foi adequado para estudos de
associação entre este polimorfismo e doenças no grupo
populacional estudado.
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